Mexican health authorities have approved the first vaccine to gain official acceptance for use against the dengue virus, which infects an estimated 390 million people every year, mostly in Asia, Africa and Latin America.
The federal medical safety agency said on Wednesday that the vaccine has undergone testing on over 29,000 patients worldwide.
The agency did not name the drug but the France-based Sanofi Pasteur identified the vaccine as Dengvaxia.
Mexico said the vaccine is aimed at people aged 9 to 45 and will be used in areas where the disease is endemic.
Globally, dengue is the fastest-growing mosquito-borne disease. The deadliest form of the disease kills 22,000 people per year, according to WHO.
The Government official news portal is maintains by the New Media Unit of the Department of Government Information and it was titled "news.lk" and commenced in mid1996 and release to Internet from March 01st, 1997.
News.lk publishes in three languages – Sinhala, Tamil and English.
+94 11 366 3040
